» Articles » PMID: 23649097

Biofilm Formation Avoids Complement Immunity and Phagocytosis of Streptococcus Pneumoniae

Overview
Journal Infect Immun
Date 2013 May 8
PMID 23649097
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus pneumoniae is a frequent member of the microbiota of the human nasopharynx. Colonization of the nasopharyngeal tract is a first and necessary step in the infectious process and often involves the formation of sessile microbial communities by this human pathogen. The ability to grow and persist as biofilms is an advantage for many microorganisms, because biofilm-grown bacteria show reduced susceptibility to antimicrobial agents and hinder recognition by the immune system. The extent of host protection against biofilm-related pneumococcal disease has not been determined yet. Using pneumococcal strains growing as planktonic cultures or as biofilms, we have investigated the recognition of S. pneumoniae by the complement system and its interactions with human neutrophils. Deposition of C3b, the key complement component, was impaired on S. pneumoniae biofilms. In addition, binding of C-reactive protein and the complement component C1q to the pneumococcal surface was reduced in biofilm bacteria, demonstrating that pneumococcal biofilms avoid the activation of the classical complement pathway. In addition, recruitment of factor H, the downregulator of the alternative pathway, was enhanced by S. pneumoniae growing as biofilms. Our results also show that biofilm formation diverts the alternative complement pathway activation by a PspC-mediated mechanism. Furthermore, phagocytosis of pneumococcal biofilms was also impaired. The present study confirms that biofilm formation in S. pneumoniae is an efficient means of evading both the classical and the PspC-dependent alternative complement pathways the host immune system.

Citing Articles

PCV13 vaccine prevents pneumococcal biofilms without affecting population within the polymicrobial biofilm.

Sempere J, Yuste J, Domenech M Front Immunol. 2024; 15:1495932.

PMID: 39555077 PMC: 11563816. DOI: 10.3389/fimmu.2024.1495932.


Essential role of proline synthesis and the one-carbon metabolism pathways for systemic virulence of .

Ramos-Sevillano E, Ercoli G, Betts M, Guerra-Assuncao J, Iverson A, Frank M mBio. 2024; 15(11):e0175824.

PMID: 39422467 PMC: 11559097. DOI: 10.1128/mbio.01758-24.


Micron-scale topographies affect phagocytosis of bacterial cells on polydimethylsiloxane surfaces.

Xu Y, Phillips K, Ren D Acta Biomater. 2024; 187:253-260.

PMID: 39214161 PMC: 11446655. DOI: 10.1016/j.actbio.2024.08.043.


The complement system: A key player in the host response to infections.

Jayaraman A, Walachowski S, Bosmann M Eur J Immunol. 2024; 54(11):e2350814.

PMID: 39188171 PMC: 11623386. DOI: 10.1002/eji.202350814.


Detection of Biofilm Production and Antibiotic Susceptibility Pattern among Clinically Isolated .

Pokhrel S, Sharma N, Aryal S, Khadka R, Thapa T, Pandey P J Pathog. 2024; 2024:2342468.

PMID: 38745848 PMC: 11090675. DOI: 10.1155/2024/2342468.


References
1.
Kadioglu A, Weiser J, Paton J, Andrew P . The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008; 6(4):288-301. DOI: 10.1038/nrmicro1871. View

2.
Coates H, Thornton R, Langlands J, Filion P, Keil A, Vijayasekaran S . The role of chronic infection in children with otitis media with effusion: evidence for intracellular persistence of bacteria. Otolaryngol Head Neck Surg. 2008; 138(6):778-81. DOI: 10.1016/j.otohns.2007.02.009. View

3.
Trappetti C, Ogunniyi A, Oggioni M, Paton J . Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease. PLoS One. 2011; 6(5):e19844. PMC: 3097209. DOI: 10.1371/journal.pone.0019844. View

4.
Sanchez C, Shivshankar P, Stol K, Trakhtenbroit S, Sullam P, Sauer K . The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog. 2010; 6(8):e1001044. PMC: 2920850. DOI: 10.1371/journal.ppat.1001044. View

5.
Terrasse R, Tacnet-Delorme P, Moriscot C, Perard J, Schoehn G, Vernet T . Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein. J Biol Chem. 2012; 287(51):42620-33. PMC: 3522263. DOI: 10.1074/jbc.M112.423731. View